Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-009837

Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)

  • Chief Financial Officer acquired 7,815 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-15 Grant or award : show line 1 in the form +7,815 279,325 D
2025-05-16 Sale : show line 2 in the form −1,929 $8.89 $17,149 277,396 D
Open-market sales · 1,929 sh · avg $8.89 · $17,149
Loading xslF345X05/form4.xml…